Unknown PHASE2 INTERVENTIONAL 4-arm NCT02866331

G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy

Phase II, Randomized, Double-blind Clinical Trial for Efficacy of G-CSF and Autologous Cord Blood Infusion in Children With Cerebral Palsy

Sponsor: Hanyang University Seoul Hospital

Conditions Cerebral Palsy

Interventions CB (autologous cord blood) G-CSF (Leucostim) Placebo (Normal saline)

Updated 7 times since 2017 Last updated: Aug 10, 2016 Started: Jul 31, 2016 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02866331, this PHASE2 trial focuses on Cerebral Palsy and remains ongoing. Sponsored by Hanyang University Seoul Hospital, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hanyang University Seoul Hospital
Ministry of Health & Welfare, Korea

Data source: Hanyang University Seoul Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea